This Option may be exercised only within the term set out in the Notice of Grant, and may be exercised during such term only in accordance with the terms of this Award Agreement. The Exercise Notice will be completed by Executive and delivered to the Company. The Exercise Notice will be accompanied by payment of the aggregate Exercise Price as to all Exercised Shares together with any applicable tax withholding.
This Option will be deemed to be exercised upon receipt by the Company of such fully executed Exercise Notice accompanied by such aggregate Exercise Price. Method of Payment. Payment of the aggregate Exercise Price will be by any of the following, or a combination thereof, at the election of Executive. Withholding Taxes.
Notwithstanding any contrary provision of this Award Agreement, no certificate representing the Shares will be issued to Executive, unless and until satisfactory arrangements as determined by the Administrator will have been made by Executive with respect to the payment of income, employment and other taxes which the Company determines must be withheld with respect to such Shares. To the extent determined appropriate by the Company in its discretion, it will have the right but not the obligation to satisfy any tax withholding obligations by reducing the number of Shares otherwise deliverable to Executive.
If Executive fails to make satisfactory arrangements for the payment of any required tax withholding obligations hereunder at the time of the Option exercise, Executive acknowledges and agrees that the Company may refuse to honor the exercise and refuse to deliver Shares if such withholding amounts are not delivered at the time of exercise. Rights as Shareholder.
Neither Executive nor any person claiming under or through Executive will have any of the rights or privileges of a shareholder of the Company in respect of any Shares deliverable hereunder unless and until certificates representing such Shares will have been issued, recorded on the records of the Company or its transfer agents or registrars, and delivered to Executive. After such issuance, recordation and delivery, Executive will have all the rights of a shareholder of the Company with respect to voting such Shares and receipt of dividends and distributions on such Shares.
No Guarantee of Continued Service. Address for Notices. Any notice to be given to the Company under the terms of this Award Agreement will be addressed to the Company at Sarepta Therapeutics, Inc. Non-Transferability of Option. This Option may not be transferred in any manner otherwise than by will or by the laws of descent or distribution and may be exercised during the lifetime of Executive only by Executive. Binding Agreement. Subject to the limitation on the transferability of this grant contained herein, this Award Agreement will be binding upon and inure to the benefit of the heirs, legatees, legal representatives, successors and assigns of the parties hereto.
Additional Conditions to Issuance of Stock. If at any time the Company will determine, in its discretion, that the listing, registration or qualification of the Shares upon any securities exchange or under any state or federal law, or the consent or approval of any governmental regulatory authority is necessary or desirable as a condition to the issuance of Shares to Executive or his or her estate , such issuance will not occur unless and until such listing, registration, qualification, consent or approval will have been effected or obtained free of any conditions not acceptable to the Company.
The Company will make all reasonable efforts to meet the requirements of any such state or federal law or securities exchange and to obtain any such consent or approval of any such governmental authority. Assuming such compliance, for income tax purposes the Exercised Shares will be considered transferred to Executive on the date the Option is exercised with respect to such Exercised Shares. In the event of the proposed dissolution or liquidation of the Company, the Administrator will notify Executive as soon as practicable prior to the effective date of such proposed transaction.
2 Pharma Stocks Flashing Buy
To the extent it has not been previously exercised, the Option will terminate immediately prior to the consummation of such proposed action. In taking any of the actions permitted under this subsection c , the Administrator will not be obligated to treat all awards, all awards held by the Executive, or all awards of the same type, similarly.
In the event that the successor corporation does not assume or substitute for the Option or portion thereof , the Participant will fully vest in and have the right to exercise all of his or her outstanding Option or portion thereof that is not assumed or substituted for. In addition, if the Option is not assumed or substituted for in the event of a Change in Control, the Administrator will notify the Participant in writing or electronically that the Option will be fully vested and exercisable for a period of time determined by the Administrator in its sole discretion, and the Option will terminate upon the expiration of such period.
For the purposes of this subsection c , the Option will be considered assumed if, following the Change in Control, the Option is given the right to purchase or receive, for each Share subject to the Option immediately prior to the Change in Control, the. Data from 3, 4 and 5 filings.
Stock values as filed, not updated for current price. Data from 13F filings. Long positions only. Financial report summary? Content analysis. From filing K FY. Financial reports View all.
2 Pharma Stocks Flashing Buy
Current reports View all. Results of Operations and Financial Condition. Regulation FD Disclosure. Departure of Directors or Certain Officers. Entry into a Material Definitive Agreement.
Sarepta Therapeutics Stock Drops on Earnings. Why Analysts Remain Hopeful.
Registration and prospectus View all. Registration of securities for employees. Automatic shelf registration. Prospectus supplement for primary offering.
Proxies View all. Additional proxy soliciting materials. DEF 14A. Definitive proxy. PRE 14A. Preliminary proxy. Other View all. Letter from SEC. Correspondence with SEC. Confidential treatment order. The volatility of a stock over a given time period. It is calculated by determining the average standard deviation from the average price of the stock over one month or 21 business days.
AMRN and SRPT stocks could shine again, if past is prologue
Historical volatility can be compared with implied volatility to determine if a stock's options are over- or undervalued. EPS is calculated by dividing the adjusted income available to common stockholders for the trailing twelve months by the trailing twelve-month diluted weighted average shares outstanding.
- Trade with Jim Cramer 14 Days Free.
- SRPT - Sarepta Therapeutics Stock Options Prices - ;
- Financials.
TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts. Annual Dividend is calculated by multiplying the announced next regular dividend amount times the annual payment frequency. If no new dividend has been announced, the most recent dividend is used.
If dividend payments are inconsistent, as with many ADRs, the annual dividend is calculated by totaling the regular dividends paid over the trailing 12 months. Beta less than 1 means the security's price or NAV has been less volatile than the market. Beta greater than 1 means the security's price or NAV has been more volatile than the market.